Acute Treatment of Migraines

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine

Sign Up For A Study

    Study Information

    Condition Migraines
    Phase III

    Conquest Research needs volunteers for a migraine trial evaluating a nasal medication designed to help treat patients suffering from acute migraine attacks. You may qualify if you:

    • Are between the age of 18 and 65

    • Have at least a 1-year history of migraines

    • Experience 2 to 8 migraine headache attacks of moderate to severe intensity per month

    Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

    Sign Up For A Study

      What To Expect


      Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

      SEE MORE
      A mature medical doctor smiling as some of his colleagues stand in the background

      Register For A Study!